A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.
Liu, C.I., Liu, G.Y., Song, Y., Yin, F., Hensler, M.E., Jeng, W.Y., Nizet, V., Wang, A.H., Oldfield, E.(2008) Science 319: 1391-1394
- PubMed: 18276850 
- DOI: 10.1126/science.1153018
- Primary Citation of Related Structures:  
2ZCO, 2ZCQ, 2ZCR, 2ZCS, 3W7F - PubMed Abstract: 
Staphylococcus aureus produces hospital- and community-acquired infections, with methicillin-resistant S. aureus posing a serious public health threat. The golden carotenoid pigment of S. aureus, staphyloxanthin, promotes resistance to reactive oxygen species and host neutrophil-based killing, and early enzymatic steps in staphyloxanthin production resemble those for cholesterol biosynthesis ...